Isolation and characterization of circulating tumor cells in colorectal cancer
Dotaz
Zobrazit nápovědu
Metastatic colorectal cancer (mCRC) is characterized by its extensive disease heterogeneity, suggesting that individualized analysis could be vital to improving patient outcomes. As a minimally invasive approach, the liquid biopsy has the potential to longitudinally monitor heterogeneous analytes. Current platforms primarily utilize enrichment-based approaches for epithelial-derived circulating tumor cells (CTC), but this subtype is infrequent in the peripheral blood (PB) of mCRC patients, leading to the liquid biopsy's relative disuse in this cancer type. In this study, we evaluated 18 PB samples from 10 mCRC patients using the unbiased high-definition single-cell assay (HDSCA). We first employed a rare-event (Landscape) immunofluorescence (IF) protocol, which captured a heterogenous CTC and oncosome population, the likes of which was not observed across 50 normal donor (ND) samples. Subsequent analysis was conducted using a colorectal-targeted IF protocol to assess the frequency of CDX2-expressing CTCs and oncosomes. A multi-assay clustering analysis isolated morphologically distinct subtypes across the two IF stains, demonstrating the value of applying an unbiased single-cell approach to multiple assays in tandem. Rare-event enumerations at a single timepoint and the variation of these events over time correlated with progression-free survival. This study supports the clinical utility of an unbiased approach to interrogating the liquid biopsy in mCRC, representing the heterogeneity within the CTC classification and warranting the further molecular characterization of the rare-event analytes with clinical promise.
- Publikační typ
- časopisecké články MeSH
... Modulation of cell cycle leads to phenotypical changes of prostate cancer cell lines 35 -- 27. ... ... Isolation and characterization of circulating tumor cells in colorectal cancer 37 -- 29. ... ... R.; Kozubik, A.: Souček, K -- Identification of cancer stem-like cell in prostate cancer cell lines and ... ... in normal and cancer cell lines 45 -- 37. ... ... PPARy ligand sensitizes prostate cancer cells to the oxaliplatin treatment 54 ...
1st edition 55 stran ; 21 cm
- MeSH
- kmenové buňky MeSH
- molekulární biologie MeSH
- nádory terapie MeSH
- nemoci cév MeSH
- Publikační typ
- abstrakty MeSH
- kongresy MeSH
- sborníky MeSH
... Pedoni 115 -- Cancer and brain disease characterization and therapy assessment by quantitative magnetic ... ... Bum 290 -- Molecular interactions between cancer cells and laminin: basis for the development of new ... ... Devilee % 296 -- A European cancer cell line resource, A. ... ... cancer, J.D. ... ... Schwartz 406 xiv -- Cell-cell, cell-matrix interactions in atherosclerotic plaque and smooth muscle differentiation ...
Biomedical and health research, ISSN 0929-6743 vol. 9
xxxix, 744 s. ; 24 cm
